1. Hygieia, a digital insulin enhancement company, received FDA clearance for its phone app that helps optimize insulin management for patients with Type 2 diabetes.
2. Keytruda received expanded use approval for the treatment of patients with melanoma with involvement of lymph nodes.
3. Premixed vancomycin injection, which is in a ready-to-use bag, for the treatment of nonpregnant patients to treat bone infections, skin infections, infective endocarditis and more.
4. Esperoct, a hemophilia A treatment, is approved for use in adults and children to reduce the frequency of bleeding episodes.
More articles on supply chain:
Supplies of bladder cancer drug are dwindling
Washington faces critically low blood supply
An interoperable insulin pump, a first-of-its-kind tropical disease drug & more: 4 recent FDA approvals
